These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

776 related items for PubMed ID: 31378890

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. LncRNA MCM3AP-AS1 promotes proliferation, migration and invasion of oral squamous cell carcinoma cells via regulating miR-204-5p/FOXC1.
    Li H, Jiang J.
    J Investig Med; 2020 Oct; 68(7):1282-1288. PubMed ID: 32690597
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Low expression of lncRNA MEG3 promotes the progression of oral squamous cell carcinoma by targeting miR-21.
    Zhang LL, Hu D, Zou LH.
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8315-8323. PubMed ID: 30556872
    [Abstract] [Full Text] [Related]

  • 7. Mechanism of LncRNA FOXC2-AC1 promoting lung cancer metastasis by regulating miR-107.
    Wu XF, Lu JT, Chen W, Wang N, Meng JC, Zhou YH.
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):690-698. PubMed ID: 30720176
    [Abstract] [Full Text] [Related]

  • 8. FOXD2-AS1 promotes malignant cell behavior in oral squamous cell carcinoma via the miR-378 g/CRABP2 axis.
    Guo S, Huang B, You Z, Luo Z, Xu D, Zhang J, Lin J.
    BMC Oral Health; 2024 May 28; 24(1):625. PubMed ID: 38807101
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. lncRNA TMEM161B-AS1 screened the onset of oral squamous cell carcinoma in HPV-infected patients, predicted poor prognosis, and regulated cell progression via modulating the miR-651-5p/BDNF axis.
    Wang M, Han Z, Wang X, Cheng Y, Cao Z, Zhang Y, Zhang Y.
    Odontology; 2024 Jul 28; 112(3):1010-1022. PubMed ID: 38376795
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. LncRNA LACAT1 promotes proliferation of oral squamous cell carcinoma cells by inhibiting microRNA-4301.
    Wang J, Huo F, Wang XR, Xu YY.
    Eur Rev Med Pharmacol Sci; 2019 Mar 28; 23(6):2427-2435. PubMed ID: 30964168
    [Abstract] [Full Text] [Related]

  • 14. LncRNA FEZF1-AS1 Modulates Cancer Stem Cell Properties of Human Gastric Cancer Through miR-363-3p/HMGA2.
    Hui Y, Yang Y, Li D, Wang J, Di M, Zhang S, Wang S.
    Cell Transplant; 2020 Mar 28; 29():963689720925059. PubMed ID: 32638620
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Long noncoding RNA OIP5-AS1 promotes the progression of oral squamous cell carcinoma via regulating miR-338-3p/NRP1 axis.
    Li M, Ning J, Li Z, Fei Q, Zhao C, Ge Y, Wang L.
    Biomed Pharmacother; 2019 Oct 28; 118():109259. PubMed ID: 31369989
    [Abstract] [Full Text] [Related]

  • 20. Long non-coding RNA FEZF1-AS1 induced progression of ovarian cancer via regulating miR-130a-5p/SOX4 axis.
    Sun Z, Gao S, Xuan L, Liu X.
    J Cell Mol Med; 2020 Apr 28; 24(7):4275-4285. PubMed ID: 32135030
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.